This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dac Slr. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Owen Clifford Mather: Innovator in Hsp90 Inhibitors
Introduction
Owen Clifford Mather is a notable inventor based in Oxfordshire, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target Hsp90 activity. His work is crucial for advancing treatments for various diseases.
Latest Patents
Mather holds a patent for "Quinazolin-oxime derivatives as Hsp90 inhibitors." This patent describes compounds of general formula (I), including stereoisomers, tautomers, pharmaceutically acceptable salts, or prodrugs. These compounds are designed to treat diseases and conditions mediated by excessive or inappropriate Hsp90 activity, such as cancers, viral infections, and inflammatory diseases.
Career Highlights
Owen Mather is associated with Dac Slr, where he applies his expertise in drug development. His innovative approach has led to advancements in therapeutic options for patients suffering from serious health conditions.
Collaborations
Mather has collaborated with notable colleagues, including Stephen Martin Courtney and Mark Whittaker. Their combined efforts contribute to the ongoing research and development in the field of Hsp90 inhibitors.
Conclusion
Owen Clifford Mather's work in developing Hsp90 inhibitors represents a significant advancement in medical science. His contributions are vital for the future of treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile